| Adverse effects of low-dose methotrexate: a randomized trial DH Solomon, RJ Glynn, EW Karlson, F Lu, C Corrigan, J Colls, C Xu, ... Annals of internal medicine 172 (6), 369-380, 2020 | 165 | 2020 |
| Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases C Cook, NJ Patel, KM D’Silva, TYT Hsu, M DiIorio, L Prisco, LW Martin, ... Annals of the rheumatic diseases 81 (2), 289-291, 2022 | 82 | 2022 |
| Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT P Wang, SE Smith, R Garg, F Lu, A Wohlfahrt, A Campos, K Vanni, Z Yu, ... RMD open 4 (1), e000593, 2018 | 46 | 2018 |
| DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study M Di Iorio, CE Cook, KMM Vanni, NJ Patel, KM D'Silva, X Fu, J Wang, ... Seminars in arthritis and rheumatism 55, 152025, 2022 | 34 | 2022 |
| Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative … TYT Hsu, KM D'Silva, NJ Patel, J Wang, AA Mueller, X Fu, L Prisco, ... The Lancet Rheumatology 3 (9), e638-e647, 2021 | 34 | 2021 |
| Coronavirus disease 2019 outcomes among recipients of anti‐CD20 monoclonal antibodies for immune‐mediated diseases: a comparative cohort study NJ Patel, KM D'Silva, TYT Hsu, M DiIorio, X Fu, C Cook, L Prisco, L Martin, ... ACR open rheumatology 4 (3), 238-246, 2022 | 31 | 2022 |
| Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study G Qian, X Wang, NJ Patel, Y Kawano, X Fu, CE Cook, KMM Vanni, ... The Lancet Rheumatology 5 (3), e139-e150, 2023 | 29 | 2023 |
| Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study G Figueroa-Parra, EL Gilbert, MO Valenzuela-Almada, S Vallejo, ... The Lancet Rheumatology 4 (11), e765-e774, 2022 | 29 | 2022 |
| A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis SK Tedeschi, DH Solomon, K Yoshida, K Vanni, DH Suh, SE Smith Rheumatology 59 (4), 900-903, 2020 | 29 | 2020 |
| Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave Y Kawano, NJ Patel, X Wang, CE Cook, KMM Vanni, EN Kowalski, ... Annals of the rheumatic diseases 81 (12), 1742-1749, 2022 | 26 | 2022 |
| Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: a cohort study NJ Patel, X Wang, X Fu, Y Kawano, C Cook, KMM Vanni, G Qian, ... Seminars in arthritis and rheumatism 58, 152108, 2023 | 25 | 2023 |
| Predictors of rheumatic immune‐related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer A Cunningham‐Bussel, J Wang, LC Prisco, LW Martin, KMM Vanni, ... Arthritis & Rheumatology 74 (3), 527-540, 2022 | 23 | 2022 |
| Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis DH Solomon, JT Giles, KP Liao, PM Ridker, PM Rist, RJ Glynn, ... Annals of the Rheumatic Diseases 82 (3), 324-330, 2023 | 22 | 2023 |
| Association between inflammation and systolic blood pressure in RA compared to patients without RA Z Yu, SC Kim, K Vanni, J Huang, R Desai, SN Murphy, DH Solomon, ... Arthritis research & therapy 20, 1-8, 2018 | 22 | 2018 |
| Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials KMM Vanni, H Lyu, DH Solomon Rheumatology 59 (4), 709-717, 2020 | 21 | 2020 |
| Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular … KMM Vanni, N Berliner, NP Paynter, RJ Glynn, J MacFadyen, J Colls, F Lu, ... ACR Open Rheumatology 2 (12), 697-704, 2020 | 20 | 2020 |
| Low‐dose methotrexate and mucocutaneous adverse events: results of a systematic literature review and meta‐analysis of randomized controlled trials R Lalani, H Lyu, K Vanni, DH Solomon Arthritis care & research 72 (8), 1140-1146, 2020 | 16 | 2020 |
| Effect of low-dose methotrexate on eGFR and kidney adverse events: a randomized clinical trial JA Sparks, KMM Vanni, MA Sparks, C Xu, LM Santacroce, RJ Glynn, ... Journal of the American Society of Nephrology 32 (12), 3197-3207, 2021 | 14 | 2021 |
| Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome SC Kim, MF Di Carli, RK Garg, K Vanni, P Wang, A Wohlfahrt, Z Yu, F Lu, ... BMC rheumatology 2, 1-7, 2018 | 14 | 2018 |
| A roadmap for investigating preclinical autoimmunity using patient-oriented and epidemiologic study designs: example of rheumatoid arthritis EN Kowalski, G Qian, KMM Vanni, JA Sparks Frontiers in Immunology 13, 890996, 2022 | 11 | 2022 |
